Blood thinners safe for people in their nineties
People aged ninety and over can safely take blood thinners. This is the conclusion of doctor of internal medicine in training Hilde Kooistra and Professor of Coagulation Disorders at the UMCG Karina Meijer. It is based on PhD research conducted by Kooistra in the UMCG, which was published in this week’s JAMA Internal Medicine. ‘This means that we will be able to prevent more strokesin older adults.’
Blood thinners are often prescribed to the over-seventy-fives to prevent clots from forming in their blood (thrombosis). Clots tend to develop in the heart of patients with atrial fibrillation, for example. If these clots reach the brain, they can cause a stroke. Stroke can lead to disability and diminished quality of life, particularly in elderly patients.
Risk of bleeding
One of the drawbacks of blood thinners is that they increase the risk of bleeding, which can also have serious implications. Current thinking is that blood thinners prescribed to the over-seventies prevent more cases of thrombosis than they cause bleeding. However, doctors are more cautious about prescribing them to patients in their nineties because it is thought that the risk of bleeding increases with age.
Data from the thrombosis service
The thrombosis service regularly checks the blood and physical condition of elderly people taking vitamin K antagonist, a type of blood thinners. For her research, Kooistra was given access to their data. ‘We compared data from around 1,100 patients in their nineties who were taking blood thinners with those of patients in their seventies and eighties. There was no difference in the incidence of bleeding between the patients in their seventies and those in their eighties. However, although the incidence of bleeding among patients in their nineties rose, the rise was not as large as previously assumed. The research shows that blood thinners are usually just as safe for patients in their nineties as they are for patients in their seventies or eighties. The risk of thrombosis is much higher than the risk of bleeding, so the advantages of the drugs outweigh the disadvantages.’
Focus on the individual
‘This research clearly shows that age should not be an issue when prescribing blood thinners’, concludes Meijer. ‘We can use the same guidelines for all elderly patients. Doctors should focus on the health of the individual instead of his or her age.’ This would mean that more ninety-year-olds could be prescribed blood thinners than is currently the case. ‘ The incidence of bleeding would not increase dramatically, but it would help to prevent stroke. ’
Read the article in Jama here: http://archinte.jamanetwork.com/article.aspx?articleid=2530903
Last modified: | 10 June 2022 08.54 a.m. |
More news
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
16 July 2024
Medicine still subjects to male bias
Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.